OP 4.6 – 00185 No associations between magnitudes of HIV-specific CTL responses on stable art and subsequent decay of intact proviruses or cell-associated HIV mRNA

OP 4.6 – 00185 No associations between magnitudes of HIV-specific CTL responses on stable art and subsequent decay of intact proviruses or cell-associated HIV mRNA

Bibliographic Details
Main Authors:	A. Ward, D. Copertino, E. Stevenson, E. McNeil, U. Chukwukere, R. Gandhi, D. McMahon, R. Bosch, J. Mellors, B. Jones, B.J. Macatangay, J.C. Cyktor, J.J. Eron
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664022001443

Similar Items

Intact proviral DNA levels decline in people with HIV on antiretroviral therapy
by: J. Cyktor, et al.
Published: (2019-12-01)

PP 7.8 – 00060 Slowing or Reversal of Decay of Intact Proviruses Over Two Decades of Suppressive ART
by: J. Cyktor, et al.
Published: (2022-12-01)

Immune activation markers associated with levels and diversity of intact HIV proviruses during HIV- HBV co-infection
by: X.Q. Wang, et al.
Published: (2019-07-01)

PP 4.16 – 00188 Investigating the Role of Naïve CD4+ T-cells as a CTL Resistant Sanctuary for Intact HIV Proviruses
by: J. Weiler, et al.
Published: (2022-12-01)

HBV-related inflammation is linked to the level of genetically intact HIV proviruses
by: X. Wang, et al.
Published: (2019-12-01)

HIV antibody and T cell responses on ART are associated with HIV DNA but not RNA
by: S.M. Keating, et al.
Published: (2017-12-01)

Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy
by: Weiwei Sun, et al.
Published: (2023-11-01)

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.
by: Rajesh T Gandhi, et al.
Published: (2017-04-01)

Characterizing HIV expression of proviruses during ART in tissues and blood
by: W.R. McManus, et al.
Published: (2017-12-01)

Single romidepsin infusions do not increase HIV expression in persons on ART (A5315)
by: D. McMahon, et al.
Published: (2017-12-01)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016-07-01)

Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.
by: Kaitlin Rainwater-Lovett, et al.
Published: (2017-01-01)

In vivo expression of unspliced HIV RNA in expanded CD4+T-cell clones containing defective or replication-competent proviruses
by: M.F. Kearney, et al.
Published: (2015-12-01)

OP 2.7 – 00057 The latency reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific CD8+ T-cells
by: D.C. Copertino, et al.
Published: (2022-12-01)

Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants
by: Bonnie Hiener, et al.
Published: (2017-10-01)

Impact of misclassified defective proviruses on HIV reservoir measurements
by: Daniel B. Reeves, et al.
Published: (2023-07-01)

Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy
by: Melissa A. Tosiano, et al.
Published: (2022-12-01)

Challenges in Quantifying Cytosine Methylation in the HIV Provirus
by: Sarah A. LaMere, et al.
Published: (2019-02-01)

Intact proviruses are enriched in the colon and associated with PD-1+TIGIT− mucosal CD4+ T cells of people with HIV-1 on antiretroviral therapyResearch in context
by: Camille Vellas, et al.
Published: (2024-02-01)

HIV reservoirs are dominated by genetically younger and clonally enriched proviruses
by: Natalie N. Kinloch, et al.
Published: (2023-12-01)

Regulatory T cells: the ultimate HIV reservoir?
by: Joseph Rocco, et al.
Published: (2018-10-01)

Whole genome sequencing of single HIV provirus and its proviral integration site for the study of HIV latency
by: C. Sun, et al.
Published: (2017-12-01)

Intact provirus and integration sites analysis in acute HIV-1 infection and changes after one year of early antiviral therapy
by: Gabriella Rozera, et al.
Published: (2022-12-01)

Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4
by: Katie Fisher, et al.
Published: (2023-01-01)

Intact proviruses from naive and effector memory T-cells match persistent viremia
by: K. Fisher, et al.
Published: (2019-12-01)

HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus
by: Andrew Musick, et al.
Published: (2019-10-01)

Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir.
by: John K Bui, et al.
Published: (2017-03-01)

Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
by: Karlsson, A, et al.
Published: (2007)

HIV-1 proviruses which are integrated into cancer-related genes are inducible
by: A. Varabyou, et al.
Published: (2017-12-01)

Dynamics of HIV-specific T cells on long-term ART differ by antigen recognised and by sex
by: Eva M. Stevenson, et al.
Published: (2019-12-01)

7 A single-cell method to detect early activation of the latent HIV provirus
by: J.P. Svensson
Published: (2017-07-01)

Intragenic proviral elements support transcription of defective HIV-1 proviruses.
by: Jeffrey Kuniholm, et al.
Published: (2021-12-01)

Chromatin maturation of the HIV-1 provirus in primary resting CD4+ T cells.
by: Birgitta Lindqvist, et al.
Published: (2020-01-01)

Sequencing HIV proviruses over time provides new insights into reservoir decay
by: D.J. VanBelzen, et al.
Published: (2017-12-01)

Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
by: Annika C Karlsson, et al.
Published: (2007-02-01)

Structured observations reveal slow HIV-1 CTL escape
by: Roberts, H, et al.
Published: (2015)

Targeting and Understanding HIV Latency: The CRISPR System against the Provirus
by: Gloria Magro, et al.
Published: (2021-09-01)

PP 4.9 – 00113 Transcription of Defective HIV Proviruses Trigger Innate Immune Responses
by: J. Kilroy, et al.
Published: (2022-12-01)

Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9
by: Alex Olson, et al.
Published: (2020-10-01)

Comparison of methods to quantify inducible HIV-1 outgrowth
by: P. Nathan Enick, et al.
Published: (2021-06-01)